866-997-4948(US-Canada Toll Free)

Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2019

Published By :

GlobalData

Published Date : Dec 2019

Category :

Medical Equipments

No. of Pages : 112 Pages

Cardiopulmonary Bypass Equipment - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Cardiopulmonary Bypass Equipment - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiopulmonary Bypass Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiopulmonary Bypass Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiopulmonary Bypass Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiopulmonary Bypass Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiopulmonary Bypass Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Cardiopulmonary Bypass Equipment Overview 8
3 Products under Development 9
3.1 Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development 9
3.2 Cardiopulmonary Bypass Equipment - Pipeline Products by Territory 10
3.3 Cardiopulmonary Bypass Equipment - Pipeline Products by Regulatory Path 11
3.4 Cardiopulmonary Bypass Equipment - Pipeline Products by Estimated Approval Date 12
3.5 Cardiopulmonary Bypass Equipment - Ongoing Clinical Trials 13
4 Cardiopulmonary Bypass Equipment - Pipeline Products under Development by Companies 14
4.1 Cardiopulmonary Bypass Equipment Companies - Pipeline Products by Stage of Development 14
4.2 Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development 16
5 Cardiopulmonary Bypass Equipment Companies and Product Overview 18
5.1 AngioDynamics Inc Company Overview 18
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Breethe, Inc. Company Overview 20
5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 CardiacAssist Inc Company Overview 21
5.3.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Circulatory Technology Inc. Company Overview 22
5.4.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Design Mentor, Inc. Company Overview 23
5.5.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Elsius Biomedical Inc Company Overview 24
5.6.1 Elsius Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Ension, Inc. Company Overview 25
5.7.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 Getinge AB Company Overview 26
5.8.1 Getinge AB Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Haemair Ltd Company Overview 27
5.9.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 Hemovent GmbH Company Overview 28
5.10.1 Hemovent GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 LivaNova PLC Company Overview 31
5.11.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Mayo Clinic Company Overview 34
5.12.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 McGowan Institute for Regenerative Medicine Company Overview 35
5.13.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 MedArray Inc. Company Overview 36
5.14.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Monash University Company Overview 39
5.15.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Nikkiso Co Ltd Company Overview 40
5.16.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 Nipro Corp Company Overview 41
5.17.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 Spectrum Medical Ltd Company Overview 43
5.18.1 Spectrum Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 45
5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45
5.20 Terumo Cardiovascular Systems Corp Company Overview 46
5.20.1 Terumo Cardiovascular Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 46
5.21 The Charles Stark Draper Laboratory Inc Company Overview 47
5.21.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.22 Thoratec Corp Company Overview 48
5.22.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 University of California San Francisco Company Overview 49
5.23.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 49
5.24 University of Michigan Company Overview 50
5.24.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 50
5.25 University of Pittsburgh Company Overview 51
5.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 51
5.26 University of Strathclyde Company Overview 52
5.26.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 52
5.27 Xenios AG Company Overview 53
5.27.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 53
6 Cardiopulmonary Bypass Equipment- Recent Developments 55
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 55
6.2 Nov 18, 2019: CE Approval for Quantum Centrifugal Pump Drive systems 57
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 57
6.4 Oct 30, 2019: LivaNova reports third quarter 2019 results 58
6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 59
7 Appendix 109
7.1 Methodology 109
7.2 About GlobalData 112
7.3 Contact Us 112
7.4 Disclaimer 112

List of Tables
Table 1: Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
Table 2: Cardiopulmonary Bypass Equipment - Pipeline Products by Territory
Table 3: Cardiopulmonary Bypass Equipment - Pipeline Products by Regulatory Path
Table 4: Cardiopulmonary Bypass Equipment - Pipeline Products by Estimated Approval Date
Table 5: Cardiopulmonary Bypass Equipment - Ongoing Clinical Trials
Table 6: Cardiopulmonary Bypass Equipment Companies - Pipeline Products by Stage of Development
Table 7: Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
Table 8: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AngioVac - Generation 3 - Product Status
Table 10: AngioVac - Generation 3 - Product Description
Table 11: AngioVac - Generation 4 - Product Status
Table 12: AngioVac - Generation 4 - Product Description
Table 13: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 14: OXY-1 - Product Status
Table 15: OXY-1 - Product Description
Table 16: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: LifeSPARC System - Product Status
Table 18: LifeSPARC System - Product Description
Table 19: Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Heart Lung Machine - Product Status
Table 21: Heart Lung Machine - Product Description
Table 22: Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 23: VentriFlo Pump - Product Status
Table 24: VentriFlo Pump - Product Description
Table 25: Elsius Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: ECMO Portable Device - Product Status
Table 27: ECMO Portable Device - Product Description
Table 28: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 29: pCAS - Product Status
Table 30: pCAS - Product Description
Table 31: Getinge AB Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Heart-Lung Machine HL 40 - Product Status
Table 33: Heart-Lung Machine HL 40 - Product Description
Table 34: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Extracorporeal Membrane Oxygenation (ECMO) Device - Product Status
Table 36: Extracorporeal Membrane Oxygenation (ECMO) Device - Product Description
Table 37: Hemovent GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Mobybox - Product Status
Table 39: Mobybox - Product Description
Table 40: Hemovent GmbH - Ongoing Clinical Trials Overview
Table 41: Mobybox - A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System for Cardiac and Respiratory Support: The MOBYBOX Trial
Table 42: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 43: LBATS - Product Status
Table 44: LBATS - Product Description
Table 45: New Oxy Apex HP Oxygenator - Product Status
Table 46: New Oxy Apex HP Oxygenator - Product Description
Table 47: Next Generation ECMO System - Product Status
Table 48: Next Generation ECMO System - Product Description
Table 49: NINO - Product Status
Table 50: NINO - Product Description
Table 51: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Heart-Lung Machine Reservoir Sensor - Product Status
Table 53: Heart-Lung Machine Reservoir Sensor - Product Description
Table 54: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Biohybrid Artificial Lung - Product Status
Table 56: Biohybrid Artificial Lung - Product Description
Table 57: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 58: ECMO Oxygenator - Adult - Product Status
Table 59: ECMO Oxygenator - Adult - Product Description
Table 60: ECMO Oxygenator - Neonatal - Product Status
Table 61: ECMO Oxygenator - Neonatal - Product Description
Table 62: ECMO Oxygenator - Pediatric - Product Status
Table 63: ECMO Oxygenator - Pediatric - Product Description
Table 64: Monash University Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Cardio By-Pass Machine - Product Status
Table 66: Cardio By-Pass Machine - Product Description
Table 67: Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Cardiopulmonary Bypass Pump - Product Status
Table 69: Cardiopulmonary Bypass Pump - Product Description
Table 70: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Extracorporeal Membrane Oxygenator - Product Status

List of Figures
Figure 1: Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
Figure 2: Cardiopulmonary Bypass Equipment - Pipeline Products by Territory
Figure 3: Cardiopulmonary Bypass Equipment - Pipeline Products by Regulatory Path
Figure 4: Cardiopulmonary Bypass Equipment - Pipeline Products by Estimated Approval Date
Figure 5: Cardiopulmonary Bypass Equipment - Ongoing Clinical Trials

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *